Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2007 1
2009 1
2012 2
2013 10
2014 16
2015 8
2016 12
2017 5
2018 6
2019 13
2020 13
2021 14
2022 27
2023 24
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean seonghwan lee (20 results)?
The estimated mediating roles of anemia-related variables in the association between kidney function and mortality: a National Health and Nutrition Examination Survey (NHANES) study.
Kim YH, Lee W, Kim KY, Kim Y, Ko A, Weon B, Lee J, Jin W, Kim DK, Kim YS, Lim CS, Lee JP; Korean Association for the study of Renal Anemia, artificial Intelligence (KARAI). Kim YH, et al. Among authors: lee j. Sci Rep. 2024 Mar 19;14(1):6621. doi: 10.1038/s41598-024-56877-7. Sci Rep. 2024. PMID: 38503784 Free PMC article.
Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
Lee J, Lee J, Kim K, Lee J, Jung Y, Hyeon JS, Seo A, Jin W, Weon B, Shin N, Kim S, Lim CS, Kim YS, Lee JP, Hwang GS, Yang SH. Lee J, et al. Kidney Int. 2024 Feb 29:S0085-2538(24)00163-7. doi: 10.1016/j.kint.2024.01.040. Online ahead of print. Kidney Int. 2024. PMID: 38431216 Free article.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
151 results